Dermata Therapeutics, Inc. (DRMA)
NASDAQ·Healthcare·Biotechnology
$0.77
+2.64%
Mkt Cap $3.87M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+674.3%
Consensus $6.00 vs current $0.77
NASDAQ·Healthcare·Biotechnology
$0.77
+2.64%
Mkt Cap $3.87M
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+674.3%
Consensus $6.00 vs current $0.77